HIPK2 and malignant colon neoplasm: In agreement with earlier studies [37,45,62], HIPK2 reduction in colon cancer tissues, compared to the normal tissues, could be considered a potential novel prognostic marker of colon cancer progression, along with high production of exomiR-1229 [73].